US Broker Ratings

Domo, Inc. (DOMO) Investor Outlook: Navigating a Potential 88% Upside

Domo, Inc. (NASDAQ: DOMO) is capturing the attention of investors with its significant potential upside of 88.42%, as reflected in the average analyst target price. Operating within the competitive technology..

Viant Technology Inc. (DSP) Stock Analysis: A 52.51% Upside on the Horizon?

Viant Technology Inc. (NASDAQ: DSP) has emerged as a compelling contender in the technology sector, particularly within the software application industry. With its headquarters in Irvine, California, this advertising technology..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: Exploring a Promising 119% Potential Upside in Biotech

Tvardi Therapeutics, Inc. (TVRD), a clinical-stage biopharmaceutical company, is garnering attention within the biotechnology sector for its innovative approach to addressing fibrosis-driven diseases. With a market capitalization of $37.06 million,..

NETCLASS TECHNOLOGY INC (NTCL): Unpacking the Challenges and Opportunities in a Volatile Market

NetClass Technology Inc (NTCL), a burgeoning player in the technology sector, specifically within the software application industry, has been catching the eye of investors looking for opportunities in emerging markets...

Marti Technologies, Inc. (MRT) Investor Outlook: Analyzing a 104% Potential Upside

Marti Technologies, Inc. (NASDAQ: MRT), a technology-driven urban transportation provider based in Istanbul, Turkey, stands at a crucial junction for investors looking to harness its growth potential. With a market..

Alumis Inc. (ALMS) Investor Outlook: Biotechnology Breakthroughs with a 79.58% Potential Upside

Alumis Inc. (NASDAQ: ALMS), a promising name in the biotechnology sector, has been capturing investor attention with its dynamic approach to treating autoimmune disorders. As a clinical-stage biopharmaceutical company based..

ServiceTitan, Inc. (TTAN) Stock Analysis: Exploring a 28% Upside Potential Amid Strong Buy Ratings

ServiceTitan, Inc. (TTAN), a leader in the technology sector with its innovative software applications, is capturing significant attention from investors. With a market capitalization of $9.92 billion, the company stands..

Olema Pharmaceuticals, Inc. (OLMA): Analyst Ratings Suggest a 41.1% Upside for This Biotech Innovator

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) is a promising player in the biotechnology sector, focusing on groundbreaking therapies for women’s cancers. As a clinical-stage biopharmaceutical company, Olema is at the forefront..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Exploring a Potential 444% Upside in the Biotech Arena

For investors with a keen eye on the biotechnology sector, Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) presents an intriguing opportunity marked by both promise and risk. With its focus on..

Neuronetics, Inc. (STIM) Stock Analysis: A 322% Upside Potential Amid Rapid Revenue Growth

Neuronetics, Inc. (NASDAQ: STIM) is catching the attention of savvy investors thanks to its remarkable potential upside of over 322% and a robust revenue growth rate of 101.30%. As a..

Erasca, Inc. (ERAS) Stock Analysis: A Biotech with a 40.80% Potential Upside and Promising Oncology Pipeline

Erasca, Inc. (NASDAQ: ERAS), a clinical-stage biotechnology company, is making waves in the healthcare sector with its focus on precision oncology. With a market cap of $1.03 billion, Erasca is..

Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Healthcare Innovator Poised for 71.52% Upside

Alpha Tau Medical Ltd. (NASDAQ: DRTS), an Israeli biotechnology company specializing in innovative cancer therapies, is capturing the attention of investors with a standout potential upside of 71.52%. Operating in..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: A 47% Potential Upside Beckons Biotech Investors

Entrada Therapeutics, Inc. (NASDAQ: TRDA) is capturing the attention of investors with its promising potential upside of 47.06%, driven by innovative biotechnology developments and strong analyst confidence. As a clinical-stage..

Compass Therapeutics, Inc. (CMPX) Stock Analysis: Biotechnology Innovator with a 154% Potential Upside

Compass Therapeutics, Inc. (NASDAQ: CMPX) is capturing the attention of investors within the healthcare sector, specifically in the biotechnology industry. Headquartered in Boston, Massachusetts, this clinical-stage company is at the..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: A Biotech Powerhouse with 18% Potential Upside

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is capturing the attention of investors with its promising pipeline in the biotechnology sector. As a company dedicated to developing innovative therapies for hematologic disorders..

Chevron Corporation (CVX) Stock Analysis: A 15.26% Potential Upside Amidst Energy Sector Volatility

Chevron Corporation (NYSE: CVX), a titan in the integrated oil and gas industry, stands as a stalwart in the energy sector with a substantial market capitalization of $301.26 billion. Based..

National Research Corporation (NRC) Stock Analysis: A Deep Dive into Its High Return on Equity and Dividend Yield

National Research Corporation (NRC), a key player in the Health Information Services industry, has carved a niche by providing analytics and insights to improve patient and employee experiences across healthcare..

Nano-X Imaging Ltd (NNOX) Stock Analysis: Unlocking a 170% Upside Potential in the Healthcare Sector

Nano-X Imaging Ltd (NNOX), an innovative player in the healthcare sector, is making waves in the field of medical imaging with its cutting-edge digital X-ray technology. Headquartered in Petah Tikva,..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Biotech Pioneer with a 325% Upside Potential

Abeona Therapeutics Inc. (NASDAQ: ABEO) is currently capturing significant attention from investors, partly due to its compelling upside potential of over 325%. As a trailblazing entity in the biotechnology sector,..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Exploring a 91.49% Potential Upside in the Healthcare Sector

Alpha Teknova, Inc. (NASDAQ: TKNO) is carving a niche in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. As a U.S.-based company with a market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds